XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2020
Cash flows from operating activities:          
Net income attributable to common stockholders $ 5,506 $ 3,570 $ 3,069 $ 2,606  
Adjustments to reconcile net income to net cash provided by operating activities:          
Premium amortization, net of discount accretion on investment securities 23     111  
Depreciation expense 530     463  
Provision for loan losses 0     2,000  
Net realized (gain) loss on equity securities (235)     83  
Net realized gain on debt securities 0     (156)  
Increase in MSR assets resulting from transfers of financial assets (297)     (182)  
Mortgage servicing rights expense, net (450)     736  
Amortization of intangible assets 399     412  
Amortization of restricted stock 171     139  
Net stock based compensation expense 3     4  
Loss on sale of office properties and equipment 6     0  
Deferred income taxes 765     (150)  
Increase in cash surrender value of life insurance (153)     (142)  
Net gain from disposals of foreclosed and repossessed assets (117)     (68)  
Gain on sale of loans held for sale, net (1,595)     (780)  
Net change in loans held for sale 2,403     3,392  
Decrease in accrued interest receivable and other assets 322     1,131  
Increase (decrease) in other liabilities 6,248     (340)  
Total adjustments 8,023     6,653  
Net cash provided by operating activities 13,529     9,259  
Cash flows from investing activities:          
Net decrease in other interest-bearing deposits 1,736     738  
Purchase of available for sale securities (50,956)     (9,985)  
Purchase of held to maturity securities (16,530)     (8,063)  
Proceeds from principal payments and sale of available for sale securities 9,368     25,149  
Proceeds from principal payments and maturities of held to maturity securities 2,629     142  
Net purchases (sales) of other investments 17     6  
Proceeds from sales of foreclosed and repossessed assets 312     997  
Net decrease (increase) in loans 45,189     (4,957)  
Net capital expenditures (462)     (423)  
Proceeds from disposal of office properties and equipment 10     0  
Net cash (used in) provided by investing activities (8,687)     3,604  
Cash flows from financing activities:          
Net decrease in short-term Federal Home Loan Bank advances 0     (64,994)  
Long-term Federal Home Loan Bank advances 0     57,500  
Federal Home Loan Bank advance termination payments (8,119)     0  
Amortization of debt issuance costs 26     16  
Net increase (decrease) in deposits 84,946     (15,647)  
Repurchase shares of common stock (2,575)     (1,838)  
Surrender of restricted shares of common stock (10)     (21)  
Cash dividends paid (2,511)     (2,372)  
Net cash provided by (used in) financing activities 71,757     (27,356)  
Net increase (decrease) in cash and cash equivalents 76,599     (14,493)  
Cash and cash equivalents at beginning of period 119,440   $ 41,347 55,840 $ 55,840
Cash and cash equivalents at end of period 196,039 $ 119,440   41,347 $ 119,440
Cash paid during the period for:          
Interest on deposits 1,658     3,238  
Interest on borrowings 1,391     1,029  
Income taxes 0     0  
Supplemental noncash disclosure:          
Transfers from loans receivable to other real estate owned ("OREO") $ 45     $ 879